Midazolam for prolonged intravenous sedation in patients with tetanus
Middle East Journal of Anesthesiology. 1993; 12 (2): 135-41
en Inglés
| IMEMR
| ID: emr-29501
ABSTRACT
Midazolam was used for prolonged sedation in ten adult patients with severe tetanus in the Intensive Care Unit for periods ranging from 10 to 50 days. An infusion was started soon after induction and adjusted according to clinical needs. All the patients were intubated and ventilated and in addition received morphine 1-2 mg/hr and alcuronium or pancuronium infusion. Two patients died from complications of tetanus. Six patients recovered from the effects of midazolam within 24 hrs of the cessation of infusion. Recovery took 48 and 72 hrs respectively in the other two patients. Midazolam is a suitable drug for long-term sedation in patients with tetanus. However, dose requirements are variable and recovery may be delayed in some patients
Buscar en Google
Índice:
IMEMR (Mediterraneo Oriental)
Asunto principal:
Midazolam
/
Hipnóticos y Sedantes
Límite:
Humanos
Idioma:
Inglés
Revista:
Middle East J. Anesthesiol.
Año:
1993
Similares
MEDLINE
...
LILACS
LIS